Targeting leukemic stem cells by Bcl-2 inhibition

Researchers at The University of Texas M. D. Anderson Cancer Center have found, in laboratory studies, that the experimental drug ABT-737 which has shown promise in some cancers, can destroy acute myeloid leukemia (AML) blast, progenitor and even stem cells that are often resistant to standard chemotherapy treatment.

The drug was powerful in its own right, the researchers say, but they found that some AML cells were themselves resistant to ABT-737, so they added another drug that knocked out this secondary resistance. Together, these agents may provide a powerful therapy against AML, and could form the basis of a new way to treat the cancer, say the scientists, whose study was published in the November 14 issue of the journal, Cancer Cell.
Continue reading “Targeting leukemic stem cells by Bcl-2 inhibition”

Advertisements

Resveratrol prevents obesity and drastically increases physical endurance.

Researchers at the Institute of Genetics and Molecular and Cellular Biology in Illkirch, France have found that resveratrol boosts the exercise capacity of muscles in mice and protects against diet-induced insulin resistance and obesity. The research was published online on November 16, 2006 in the journal Cell.
Continue reading “Resveratrol prevents obesity and drastically increases physical endurance.”

‘Tribbles’ protein implicated in common and aggressive form of leukemia

Researchers at the University of Pennsylvania School of Medicine have identified a new protein associated with acute myelogenous leukemia (AML). Several lines of evidence point to a protein called Tribbles, named after the furry creatures that took over the starship Enterprise in the original Star Trek series. Tribbles was first described in fruit flies.

“Tribbles had never been directly linked to human malignancy,” says senior author Warren S. Pear, MD, PhD, Associate Professor of Pathology and Laboratory Medicine. “This is a new protein to human cancer and has a specific and overwhelming effect when expressed in hematopoietic stem cells, the cell type that gives rise to all elements of the blood.”
Continue reading “‘Tribbles’ protein implicated in common and aggressive form of leukemia”

Vaccine for brain tumors shows promising results

A vaccine for treating a recurrent cancer of the central nervous system that occurs primarily in the brain, known as glioma, has shown promising results in preliminary data from a clinical trial at UCSF Medical Center.

Findings from the first group of six patients in the study, being conducted at the UCSF Brain Tumor Research Center, showed that vitespen (trademarked as Oncophage), a vaccine made from the patient’s own tumor, was associated with tumor-specific immune response in patients with recurrent, high-grade glioma.
Continue reading “Vaccine for brain tumors shows promising results”

Neuroscientists break code on sight

In the sci-fi movie “The Matrix,” a cable running from a computer into Neo’s brain writes in visual perceptions, and Neo’s brain can manipulate the computer-created world. In reality, scientists cannot interact directly with the brain because they do not understand enough about how it codes and decodes information.

Now, neuroscientists in the McGovern Institute at MIT have been able to decipher a part of the code involved in recognizing visual objects. Practically speaking, computer algorithms used in artificial vision systems might benefit from mimicking these newly uncovered codes. Continue reading “Neuroscientists break code on sight”

Study Shows Abnormal Colon Growths Less Likely in Those Who Drink Red Wine

People who drink three or more glasses of red wine a week are less likely to get the abnormal colon growths that can lead to cancer, according to a new study.

The study doesn’t prove red wine prevents or treats colon cancer, and the researchers aren’t recommending red wine for colon cancer prevention. But they suggest that a compound found in grapes and red wine – the antioxidant resveratrol — may cut the odds of getting abnormal colon growths that can become cancerous.

Read rest of the story at WebMD

Cell transplants restore sight in mice

Scientists have successfully transplanted light-sensing cells called photoreceptors, which are immature retinal stem cells, directly into the eyes of mice and restored their visual function. The mice had eye damage similar to that seen in many human eye diseases. Experts welcomed the study, published in the magazine Nature, saying it was “stunning” research.

The achievement is based on a novel technology in which the cells are introduced at a particular stage in their development. It was carried out at the London Institute of Ophthalmology using a novel approach developed at the University of Michigan Kellogg Eye Center to tag rod precursor cells and prepare them for transplantation.

_42292564_ret_stem_cells_203in.gif
Continue reading “Cell transplants restore sight in mice”